Skip to main content

Table 4 Treatment and complications

From: Long-term outcome in new onset refractory status epilepticus: a retrospective study

Number of AEDs (median[IQR])

5 [4–7]

Duration of treatment with anesthetic agents (days, median[IQR])

8 [6–18]

Need of invasive mechanical ventilation, n (%)

24 (96)

Duration of invasive mechanical ventilation (days, median[IQR])

17 [9–25]

Need of vasopressor support, n (%)

18 (72)

Duration of vasopressor support (days, median[IQR])

7 [1–16]

Need of tracheostomy, n (%)

15 (60)

ICU complications, n (%)

25 (100)

 Neurological, n (%)

18 (72)

  Delirium

5

  Neurocognitive deficits

13

  Focal deficits

3

  CIP/CIM

9

 Infections, n (%)

18 (72)

  VAP

13

  UTI

8

  CRBSI

2

 Respiratory, n (%)

16 (64)

  Aspiration pneumonia

6

  ARDS

2

  Atelectasis

3

  Others

6

 Metabolic, n (%)

14 (56)

 Gastrointestinal, n (%)

10 (40)

 Cardiac, n (%)

9 (36)

  Arrhythmia

8

  NSTEMI

1

Length of stay on ICU (days, median[IQR])

21 [18–31]

Length of stay in hospital (days, median[IQR])

39 [26–55]

  1. AED Antiepileptic drugs; EEG Electroencephalogram; ICU Intensive care unit
  2. Data are present as counts/percentages, mean ± standard deviation (SD), or as median including the interquartile range (IQR), as appropriate. CIP/CIM critical illness polyneuropathy/ myopathy; VAP ventilator-associated pneumonia; UTI urinary tract infection; CRBSI catheter-associated bloodstream infection; ARDS acute respiratory distress syndrome; NSTEMI non-ST-elevation myocardial infarction